| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |